PANews reported on February 12 that according to the official announcement of Humanity Protocol, Nasdaq-listed company Prenetics Global Limited is cooperating with Humanity Protocol to use Prenetics' genetic testing capabilities to support decentralized identity authentication. At the same time, it announced the establishment of a strategic cryptocurrency reserve to promote innovation in the intersection of blockchain, healthcare and decentralized science (DeSci).

As part of this dual initiative, Prenetics has committed to an initial investment of $1 million in H tokens, $250,000 in Bitcoin and $250,000 in SOL. These allocations will be reviewed quarterly to assess further investment opportunities, highlighting the company's strategic intent to incorporate digital assets into the company's balance sheet. As of December 31, 2024, Prenetics had a cash and short-term asset balance of $84.87 million.

Through this partnership, Prenetics will join the Humanity Protocol as an authenticator and incorporate its flagship service CircleDNA into the protocol’s infrastructure. This integration enables the issuance of blockchain-based “personal identity” credentials, providing highly secure and Sybil-resistant identity verification using DNA testing.